| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/02/2002 | US20020053096 Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a beta-C-4-oxygenase activity for biotechnological production of (3S,3'S) astaxanthin and its specific expression in chromoplasts of higher plants |
| 05/02/2002 | US20020053095 Propagating transgenic plant; obtain sample, incubate with chemical intermediates, propagate plant |
| 05/02/2002 | US20020053094 Expression of eukaryotic peptides in plant plastids |
| 05/02/2002 | US20020053093 By use of biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen |
| 05/02/2002 | US20020053091 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 05/02/2002 | US20020052490 Nucleotide sequences coding polypeptide for use as tool in immunotherapy |
| 05/02/2002 | US20020052489 Nuclear bindng protein for use as tools in controlling gene transcription |
| 05/02/2002 | US20020052487 Transcripts of the MHC class I HLA-G gene and their applications |
| 05/02/2002 | US20020052485 Polynucleotides for use in recombinant adeno-associated virus virion production |
| 05/02/2002 | US20020052484 Detecting amino acid sequences which are receptive to microorganismal surfaces; generate library, incubate with cells, elute bound vector, amplify vector, sequence nucleotide and determine coded amino acid sequence |
| 05/02/2002 | US20020052483 Intestinal trefoil proteins |
| 05/02/2002 | US20020052482 Covalently linked oligonucleotide minor grove binder conjugates |
| 05/02/2002 | US20020052481 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4 -IgG2 immunoconjugates, and uses thereof |
| 05/02/2002 | US20020052477 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
| 05/02/2002 | US20020052476 Nucleotide sequences which code polypeptide for use in treating osteoporosis, tumor metastasis, microbial infections, viral infection, sepsis, inflammation, vision defects, cachicia and muscle disorders |
| 05/02/2002 | US20020052475 Cytokines for use in the treatment of autoimmune disease, inflammation, arthritis and multiple sclerosis |
| 05/02/2002 | US20020052472 ama |
| 05/02/2002 | US20020052471 Human procalcitonin and the preparation and use thereof |
| 05/02/2002 | US20020052334 Antisense oligonucleotide, a ribozyme, a protein, a polypeptide, an antibody, or a small molecule. |
| 05/02/2002 | US20020052333 Therapeutic use of cis-element decoys in vivo |
| 05/02/2002 | US20020052331 Of a capped target mRNA; oligonucleoides that inhibit protein translation directly via interference with ribosome assembly. |
| 05/02/2002 | US20020052316 Bax-mediated apoptosis modulating reagents and methods |
| 05/02/2002 | US20020052311 Methods and compostions for the treatment and/or diagnosis of neurological diseases and disorders |
| 05/02/2002 | US20020052047 Nucleotide sequences for use as tools in the generation of disease resistant plants |
| 05/02/2002 | US20020052046 Method of improving the primary energy metabolism of mammalian cell lines |
| 05/02/2002 | US20020052043 Human G-protein coupled receptors |
| 05/02/2002 | US20020052038 Polypeptide for use in the treatment of viral diseases and cancer |
| 05/02/2002 | US20020052037 Ribozyme for use as tool in genetic engineering |
| 05/02/2002 | US20020052036 Mutant B-type DNA polymerases exhibiting improved performance in PCR |
| 05/02/2002 | US20020052035 18891, a novel human lipase |
| 05/02/2002 | US20020052033 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 05/02/2002 | US20020052028 Bio-intermediates for use in the chemical synthesis of polyketides |
| 05/02/2002 | US20020052027 IL-17 homologous polypeptides and therapeutic uses thereof |
| 05/02/2002 | US20020052026 Expressing preferential polypeptides in culture; obtain prokaryotic cells, culture, recover preferential polypeptide |
| 05/02/2002 | US20020052023 Nucleotide sequences coding enzymatic polypeptide; for use as fungicides and herbicides |
| 05/02/2002 | US20020052022 Molecular cloning of a chemokine like 7TMR (AXOR87) |
| 05/02/2002 | US20020052020 Novel orphan receptors |
| 05/02/2002 | US20020052018 Inward rectifier, g-protein activated, mammalian, potassium channels and uses thereof |
| 05/02/2002 | US20020052012 Method of measuring plasma membrane targeting of GLUT4 |
| 05/02/2002 | US20020052005 Construction and screening of lantibody display libraries |
| 05/02/2002 | US20020051998 Library cells; for use in generation of carotenoids |
| 05/02/2002 | US20020051988 Inhibition of amyloid protein bnding to neuronal receptor; obtain cell, incubate with modulator, monitor amyloid protein activity |
| 05/02/2002 | US20020051987 Screening agglomerations for clones containing preferential enzymatic polypeptides; obtain sample of agglomeration, culture, incubate with probes, hybridize probe, detect signal, recover clone associated with signal |
| 05/02/2002 | US20020051984 Nucleotide sequences coding cell proliferation protein; for use in the treatment of cancer, wounds, inflammation, arthritis, psoraisis, vision and cell proliferation defects |
| 05/02/2002 | US20020051982 Novel BLR molecules affecting antibiotic susceptibility |
| 05/02/2002 | US20020051980 Methods for modulating the activation of a lymphocyte expressed G protein coupled receptor involved in cell proliferation, autoimmunity and inflammation |
| 05/02/2002 | US20020051979 Capillary bundles for use in the detection of preferential particle in sample |
| 05/02/2002 | US20020051976 Methods and compositions for polypeptide engineering |
| 05/02/2002 | US20020051970 Microarray-based subtractive hybridization |
| 05/02/2002 | US20020051969 Modulatory polypeptide; for use in the treatment of bone disorders |
| 05/02/2002 | US20020051966 Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease |
| 05/02/2002 | US20020051965 Modifications of the VEGF receptor-2 protein and methods of use |
| 05/02/2002 | US20020051790 Helicobacter pylori; antigen of given amino acid sequences; superoxide dismutase in the form of a vaccine |
| 05/02/2002 | US20020051782 Anti-CCR2 antibodies and methods of use therefor |
| 05/02/2002 | US20020051781 CC-chemokine receptor 2 (CCR2) bound by an immunoglobulin or an antigen-binding fragment |
| 05/02/2002 | US20020051780 Bind at the same time to the T-cell receptor complex, to tumour- associated antigens on a tumour cell, and, via the Fc portion of the bispecific antibody |
| 05/02/2002 | US20020051769 Gene delivery vectors and their uses |
| 05/02/2002 | US20020051768 Encapsidated recombinant poliovirus nucleic acid and methods of making and using same |
| 05/02/2002 | US20020051764 Microbial agricultural chemical |
| 05/02/2002 | US20020051763 Recombinant viral genome and nucleic acid sequence, carried by one or two plasmid supports, transcomplementing each other and allowing the host cell to produce defective infectious viruses |
| 05/02/2002 | US20020051760 Method for screening a substance having promoting activity on hair growth |
| 05/02/2002 | EP1202065A1 Net, a transcription factor of the TCF family, as regulator of angiogenic expression. |
| 05/02/2002 | EP1201770A2 Oligonucleotide for highly sensitive detection of hepatitis c virus and method for detection thereof |
| 05/02/2002 | EP1201769A2 Gene expression monitoring using universal arrays |
| 05/02/2002 | EP1201768A2 Amplification using modified primers |
| 05/02/2002 | EP1201766A1 Cell line comprising the promoter of cyclooxygenase-2 (cox-2) and a witness gene, and use thereof in the search of cox-2 transcriptional induction selective inhibitors |
| 05/02/2002 | EP1201764A2 Assays for identifying phosphatase inhibitors |
| 05/02/2002 | EP1201761A1 Method of constructing recombinant adenovirus vector |
| 05/02/2002 | EP1201760A1 Influenza virus vector for human dendritic cells |
| 05/02/2002 | EP1201759A1 Trap vector and gene trapping method by using the same |
| 05/02/2002 | EP1201758A1 Microorganisms and method for L-arginine production by fermentation |
| 05/02/2002 | EP1201757A2 Method for preparing water soluble polypeptides |
| 05/02/2002 | EP1201756A2 Method for preparing water soluble polypeptides |
| 05/02/2002 | EP1201755A1 Gene of human brain type pgt |
| 05/02/2002 | EP1201754A1 Apoptosis-associated factor |
| 05/02/2002 | EP1201753A1 Methods for the analysis of non-proteinaceous components using a protease from a bacillus strain |
| 05/02/2002 | EP1201751A1 Method for selecting highly functional nucleic acid molecules within cells |
| 05/02/2002 | EP1201750A1 Synthetic viruses and uses thereof |
| 05/02/2002 | EP1201747A1 Process for producing gamma-glutamylcysteine |
| 05/02/2002 | EP1201676A2 PNA-DNA-PNA chimeric macromolecules |
| 05/02/2002 | EP1201246A2 Use of thrombopoietin as a medicament for the therapy and prevention of thrombocytopenia |
| 05/02/2002 | EP1200820A2 Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays |
| 05/02/2002 | EP1200670A1 Electrophoresis-assisted staining of materials |
| 05/02/2002 | EP1200628A2 Attachment of oligonucleotides to solid supports through schiff base type linkages for capture and detection of nucleic acids |
| 05/02/2002 | EP1200627A1 Method for detecting nucleic acid target sequences involving in vitro transcription from an rna polymerase promoter |
| 05/02/2002 | EP1200626A1 Method for amplification of nucleic acids |
| 05/02/2002 | EP1200625A1 Methods for determining the specificity and sensitivity of oligonucleotides for hybridization |
| 05/02/2002 | EP1200624A2 Multiplexed strand displacement for nucleic acid determinations |
| 05/02/2002 | EP1200623A2 Diagnostic method comprising wt1 sequences |
| 05/02/2002 | EP1200622A1 Adenovirus carrying gag gene hiv vaccine |
| 05/02/2002 | EP1200621A2 Genetic test for detecting a predisposition to a disease associated with abnormal vegf gene expression |
| 05/02/2002 | EP1200617A2 Methods for conditional transgene expression and trait removal in plants |
| 05/02/2002 | EP1200616A2 Enhanced delivery via serpin enzyme complex receptor ligands |
| 05/02/2002 | EP1200615A2 Nucleic acid molecules derived from plants which code for enzymes which are involved in the synthesis of starch |
| 05/02/2002 | EP1200614A1 Herbicide resistant transgenic plants with mutated alpha-tubulin |
| 05/02/2002 | EP1200613A2 Agrobacterium-mediated plant transformation method |
| 05/02/2002 | EP1200612A2 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants |
| 05/02/2002 | EP1200611A1 Herbicide-tolerant protoporphyrinogen oxidase |
| 05/02/2002 | EP1200610A1 Gene controlling shoot branching in plants |
| 05/02/2002 | EP1200609A1 Method for obtaining isogenic transgenic lines |